Recent HIMSS study found that the health IT gender gap has grown wider in the last ten years.
Award calls for outstanding ICT projects in healthcare to be nominated as industry best practice.
New labelling design based on global consumer research.
The Slovenian Tourist Board (STB) puts sustainability at the core of development and promotional activities and aims at a more responsible behaviour towards the environment and the positioning of green Slovenia in the world.
The Energy Union? It starts at home
EPRA Developed Europe Real Estate Index hits 100-constituent milestone and passes EUR 200 billion market cap level
EPRA Developed Europe Real Estate Index hits 100-constituent milestone and passes EUR 200 billion market cap level.
EU Dog & Cat Alliance event held today in the European Parliament to discuss the next steps to safeguard companion animal health and welfare, public health and consumer protection.
Last 20th May 2016 a group of European experts in paediatric cancer radiotherapy and imaging officially kicked-off the project QUARTET (Quality and Excellence in Radiotherapy and Imaging for Children and Adolescents with Cancer across Europe in Clinical Trials) in Brussels.
IFAH-Europe Welcomes G7 Summit’s Report Urging One Health Approach to AMR and Call to Incentivise R&D
Brussels, 27 May 2016 – At the close of the Summit in Ise-Shima (Japan), G7 leaders issued a declaration outlining their current thinking on antimicrobial resistance. In advance of this Summit meeting, IFAH-Europe had called on the G7 Summit leaders to consider a holistic One Health approach in dealing with antimicrobial resistance (AMR) and infectious diseases, as a reminder to policy-makers that AMR is not only a topic of concern for human and public health, but also for animal health.
Overcoming cancer is possible today, but many European childhood cancer survivors still suffer from considerable treatment-related side-effects throughout their lives.
DISCUSSION | Why Culture Matters Senior Lecturer Radu Cinpoes in conversation with artist Dan Perjovschi
DISCUSSION | Why Culture Matters Senior Lecturer Radu Cinpoes in conversation with artist Dan Perjovschi.
Brussels, 19 May 2016 – The final report of the O’Neill Review on Antimicrobial Resistance (AMR), released today, overall makes some good recommendations in terms of encouraging innovation for the quick development of new diagnostics, promoting the use of vaccines and alternatives to antibiotics, improving surveillance of AMR and antibiotic consumption in both people and animals, as well as endorsing better incentives to encourage investment for new medicines and improving existing ones, as well as the setting up of a Global Innovation Fund.
Brussels, 19th May 2016: A report published today by the independent Review of Antimicrobial Resistance clearly links the AMR problem with the world’s deadliest infectious disease: tuberculosis (TB). With drug resistant TB (DR-TB) being particularly fierce in Europe, the European Union should urgently develop a plan to tackle the disease across its policies in the wider region.
Session topics include: awareness for informal carers, sexual health and robotics for active & assisted living
EADV launches Global Call to Action to protect outdoor workers from skin cancer caused by the sun.
Dutch Minister and Secretary of State for Health, Welfare and Sport amongst keynote speakers
IFAH-Europe Welcomes New ESVAC Strategy 2016-2020, should give fuller picture of antibiotic consumption in animals.
Brussels, 8 April 2016 – EuropaBio is highly concerned that the EU Commission continues the same practices of maladministration which were criticised by the European Ombudsman as recently as January 2016.
Johnson & Johnson Announces Launch of New Global Public Health Strategy at Opening of New Operations in Africa
Cape Town, South Africa, (April 6, 2016) – Johnson & Johnson today announced the official launch of its global public health strategy at the opening of its companies’ on-the-ground global public health operations in Cape Town, South Africa.
Lugano, Switzerland – The latest article to appear on ESMO Open highlights ESMO’s hope that the 2015 WHO Model List of Essential Medicines (EML) will empower oncologists and advocates to demand routine availability of the medicines considered essential to guarantee quality care of cancer patients.
Janssen disease interception unit advances a growing venture portfolio focused on intercepting diseases prior to onset
24 global collaborations established within the first year include new partnerships with Boston University School of Medicine and the Agency for Science, Technology and Research in Singapore.
Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium
Johnson & Johnson Innovation, JLINX will offer scientists and entrepreneurs access to venture funding, R&D expertise and state-of-the-art facilities. JLINX is designed to accelerate early-stage transformative innovation, including an emphasis on the human microbiome as well as broader life-science research.